close android install prompt
Device showcase
Download the app!
INSTALL
Pediatrics Central
  • Home
  • Favorites
  • Notes
  • Prime PubMed
  • Mobile
  • Browse
Log in
Refine your search:
54All Results
5-Minute Pediatric Consult5-Minute Pediatric Consult
Davis's Drug GuideDavis's Drug Guide
Johns Hopkins ABX GuideJohns Hopkins ABX Guide
CalculatorsCalculators
Tuberculosis, Latent
54 results
1 - 54
  • Johns Hopkins ABX GuideTuberculosis, Latent
    • PATHOGENS
    • CLINICAL
    • DIAGNOSIS
    • TREATMENT
      • Adults (HIV negative)
      • Adults (HIV positive)
      • Children under 18 yrs
    • FOLLOW UP
    • OTHER INFORMATION
    • Basis for recommendation
    • References
  • Davis Drug Guiderifapentine
    • Indications
    • Route/Dosage
  • Johns Hopkins ABX GuideRifapentine
    • INDICATIONS
      • FDA
    • Basis for recommendation
    • References
    • COMMENTS
  • Davis Drug Guidesatralizumab
    • Contraindication/Precautions
  • 5 Minute Pediatric ConsultTuberculosis
    • Basics
      • Epidemiology
      • General Prevention
    • Additional Reading
    • FAQ
  • Davis Drug Guideinebilizumab
    • Contraindication/Precautions
    • Assessment
  • Davis Drug Guidetildrakizumab
    • Assessment
  • Davis Drug Guidecanakinumab
    • Implementation
  • Davis Drug Guidebelatacept
    • Implementation
    • Contraindication/Precautions
  • Johns Hopkins ABX GuideIsoniazid
    • Basis for recommendation
    • References
    • USUAL ADULT DOSING
  • Davis Drug Guideteriflunomide
    • Adverse Reactions/Side Effects
  • Johns Hopkins ABX GuidePyrazinamide
    • References
  • Johns Hopkins ABX GuideBedaquiline
    • INDICATIONS
      • FDA
  • Johns Hopkins ABX GuidePretomanid
    • INDICATIONS
      • FDA
  • Johns Hopkins ABX GuideTuberculosis, Active
    • CLINICAL
    • DIAGNOSIS
  • Davis Drug GuideinFLIXimab
    • Contraindication/Precautions
    • Assessment
  • Davis Drug Guidecertolizumab
    • Assessment
  • Davis Drug Guidevedolizumab
    • Implementation
  • Davis Drug Guideabatacept
    • Assessment
  • Davis Drug Guidegolimumab
    • Implementation
    • Assessment
  • Davis Drug Guidebaricitinib
    • Assessment
  • Johns Hopkins ABX GuideHIV, Initial Evaluation
    • COMPREHENSIVE EVALUATION
      • Baseline labs
  • Johns Hopkins ABX GuideTaenia solium
    • TREATMENT
      • General considerations
  • Davis Drug Guidedeflazacort
    • Assessment
  • Davis Drug Guideadalimumab
    • Assessment
  • Johns Hopkins ABX GuideParacoccidioides brasiliensis
    • CLINICAL
  • Johns Hopkins ABX GuideRifampin
    • References
  • Johns Hopkins ABX GuideScreening for and Prevention of Infectious Diseases in Special Populations
    • CLINICAL
  • Davis Drug Guideruxolitinib (systemic)
    • Assessment
  • Johns Hopkins ABX GuideHistoplasma capsulatum
    • CLINICAL
  • 1 - 54 of 54 records
Your free 1 year of online access expired  .

Want to regain access to Pediatrics Central?

Log in to Pediatrics Central

Note: Your username may be different from the email address used to register your account.

Contact Support

If you need further assistance, please contact Support.
  • unboundmedicine.com/support
  • support@unboundmedicine.com
  • 610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)
Password reset sent
Username sent
Forgot your username or password?
Purchase Pediatrics Central
New to Pediatrics Central?
Purchase a subscription
A Pediatrics Central subscription is required to
Already have an account?Log In
Purchase Pediatrics Central
New to Pediatrics Central?
Purchase a subscription
Unbound Medicine logo
  • Home
  • Contact Us
  • Privacy / Disclaimer
  • Terms of Service
  • Log in

© 2000–2025 Unbound Medicine, Inc. All rights reserved

CONNECT WITH US

facebookinstagramyoutubeLinkedIn

25.09.24-25.09.24_05